National Cancer Institute Archives
Study to evaluate how environment impacts cancer risk
Oct. 21, 2021—Vanderbilt-Ingram Cancer Center is leading an ambitious project to assess the impact of environmental exposures on cancer risk for people living in Southern states.
Eng named co-chair of NCI clinical trials steering committee
Sep. 23, 2021—Vanderbilt's Cathy Eng, MD, has been elected co-chair of the National Cancer Institute (NCI) Gastrointestinal Cancer Steering Committee.
Ciombor chosen for NCI clinical investigator team leadership award
Jul. 15, 2021—Kristen Ciombor, MD, MSCI, is one of 10 physicians nationwide selected by the National Cancer Institute (NCI) for the 2021 Cancer Clinical Investigator Team Leadership Award.
VUMC joins national effort to improve disease prediction in diverse populations
Jun. 16, 2021—Vanderbilt University Medical Center will participate in a new federal initiative aimed at improving the use of polygenic risk scores (PRS) to predict complex diseases in diverse populations.
Vanderbilt-Ingram Cancer Center calls for action to get cancer-preventing HPV vaccination back on track
May. 27, 2021—A significant reduction in annual well visits and immunizations during the COVID-19 pandemic has led to a vaccination gap among U.S. children and adolescents, especially with the human papillomavirus (HPV) vaccine for cancer prevention.
People at high genetic risk for colorectal cancer benefit more from lifestyle changes
May. 13, 2021—People with a high polygenic risk score for colorectal cancer could benefit more at preventing the disease by leading healthy lifestyles than those at lower genetic risk, according to a study by Vanderbilt researchers published in the April issue of The American Journal of Clinical Nutrition.
VUMC, Case Western apply artificial intelligence to “customize” oral cancer treatment
Jan. 5, 2021—Researchers at Vanderbilt University Medical Center and Case Western Reserve University in Cleveland have been awarded a five-year, $3.3 million grant by the National Cancer Institute to apply artificial intelligence (AI) to help customize treatment for oral cancer patients.
Pal named to cancer research national leadership posts
Dec. 28, 2020—Tuya Pal, MD, Ingram Professor of Cancer Research and associate director for Cancer Health Disparities at Vanderbilt-Ingram Cancer Center, has been named to two cancer research leadership posts.
NCI director urges action to address delayed cancer diagnoses
Nov. 23, 2020—Delayed cancer diagnoses and treatment due to concerns about potential coronavirus exposure will lead to collateral deaths beyond the pandemic, National Cancer Institute (NCI) Director Ned Sharpless, MD, said Thursday during a virtual visit at Vanderbilt University Medical Center.
Rini to lead NCI study of COVID-19 in cancer patients
Oct. 29, 2020—Brian Rini, MD, is leading a study launched by the National Cancer Institute (NCI) that will closely monitor cancer patients who acquire COVID-19 with the goal of providing highly detailed data to guide future care.
Initiative seeks to extract cancer phenotypes from electronic health records
Oct. 15, 2020—The National Cancer Institute (NCI) has funded the development of interactive visual tools that will allow researchers to extract cancer phenotypes from electronic medical records.
VICC receives ‘exceptional’ score with renewal as an NCI-Designated Comprehensive Cancer Center
Sep. 29, 2020—Vanderbilt-Ingram Cancer Center (VICC) received an overall “exceptional” score for its research impact and excellence in patient care. This achievement merits renewed funding from the National Cancer Institute (NCI) and places it once again in a top group of NCI Comprehensive Cancer Centers.